FLSM
VALN

Frazier Life Sciences Management’s Valneva VALN Stock Holding History

Frazier Life Sciences Management’s Portfolio VALN Stock Details VALN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Hold
2,291,666
– – 0.26% 37
2026
Q1 		$14.3M Hold
2,291,666
– – 0.37% 32
2025
Q4 		$20.2M Hold
2,291,666
– – 0.54% 30
2025
Q3 		$28M Buy
2,291,666
+833,333
+57% +$7.12M 0.84% 26
2025
Q2 		$8.24M Buy
+1,458,333
New +$9.25M 0.33% 40

Other funds holding VALN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $289M AUM 60.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Frazier Life Sciences Management's VALN Position: Q2 2026 in Review

Frazier Life Sciences Management held its Valneva (VALN) position steady in Q2 2026 at 2,291,666 shares worth $12M. The position accounts for 0.26% of the portfolio, ranked #37.

Frazier Life Sciences Management first reported a position in VALN in Q2 2025 and has held it in 5 quarters since. The position peaked at $28M in Q3 2025. 20 funds tracked by Wall St. Rank hold VALN as of Q2 2026.

  • Frazier Life Sciences Management held 2,291,666 shares of Valneva worth $12M as of Q2 2026.
  • Frazier Life Sciences Management left its Valneva share count unchanged in Q2 2026.
  • Valneva made up 0.26% of Frazier Life Sciences Management's portfolio in Q2 2026, its #37 holding.
  • Frazier Life Sciences Management first reported a position in Valneva in Q2 2025 and has held it in 5 quarters since.
  • Frazier Life Sciences Management's Valneva position peaked at $28M in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Valneva as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.